Together, these results demonstrate that leptin action on reducing T1D hyperglycemia is mediated through inhibition of GABAArc neurons, and that aberrant activation of Arc neurons, including AgRP neurons, contributes significantly to both pathogenesis of T1D hyperglycemia and leptin action on reversal of T1D hyperglycemia. The gene discussed is LEP; the disease is type 1 diabetes mellitus.